Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
Auston Cherbonneaux, Science Communicator, Author, Publisher, shared a post on LinkedIn about an article by Marco Witkowski, published in Nature Medicine, adding:
“Ingredient Alert
Erythritol (common non caloric sweetener) has evidence to suggest it compromises the blood-brain barrier over time.
This one is a bit more complicated. Still, enough evidence to start taking extreme caution for populations vulnerable to stroke, cardiac events, and thrombosis.
First, a study of about 1000 people suggests that people who are in the upper quartile of erythritol in blood were twice as likely to suffer a major cardiac event compared to the first quartile.
The conclusion to the study referenced in the article [Abstract]:
‘Our findings reveal that erythritol is both associated with incident MACE risk and fosters enhanced thrombosis. Studies assessing the long-term safety of erythritol are warranted.’
Second, experimental finding to this point is only on cells in a petri dish, next step is “blood vessels on a chip” to better mimic physiology.
I don’t need a third.
This is going on the ‘habitual extreme hazard‘ list.”
Title: The artificial sweetener erythritol and cardiovascular event risk
Authors: Marco Witkowski, Ina Nemet, Hassan Alamri, Jennifer Wilcox, Nilaksh Gupta, Nisreen Nimer, Arash Haghikia, Xinmin S. Li, Yuping Wu, Prasenjit rasad Saha, Ilja Demuth, Maximilian König, Elisabeth Steinhagen-Thiessen, Tomas Cajka, Oliver Fiehn, Ulf Landmesser, W. H. Wilson Tang, Stanley L. Hazen

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines